文献速递结核与非结核分枝杆菌

FluoroType MTB与MTBDR VER 2.0检测结核分枝杆菌复合群及异烟肼、利福平耐药性的诊断准确性

Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance.
PubMed 文献 · Clin Microbiol Infect · 2021-04-30

本研究评估了FluoroType MTB和MTBDR VER 2.0两种新分子检测方法联合手动与自动DNA提取对耐药结核病的诊断准确性。研究纳入360例Xpert Ultra MTBC阳性患者和250例阴性患者的痰标本,以GenoType MTBDRplus为参考,Sanger测序解决不一致。结果显示FluoroType MTB VER 2.0检测MTBC的敏感性与MTBDR VER 2.0相似,且MTBDR VER 2.0对MTBC及利福平、异烟肼耐药的诊断准确性与先前报道的VER 1.0相当。

要点

  • FluoroType MTB VER 2.0检测MTBC敏感性:手动提取91.6%(294/321),自动提取92.1%(305/331)。
  • MTBDR VER 2.0检测MTBC敏感性:手动提取89.8%(291/324),自动提取87.7%(291/332)。
  • MTBDR VER 2.0对MTBC及利福平、异烟肼耐药的诊断准确性与VER 1.0相当。

核心结论

  • FluoroType MTB和MTBDR VER 2.0联合自动DNA提取与PCR设置平台可能提高实验室检测MTBC及利福平、异烟肼耐药的效率,并有望用于集中式分子药敏检测模式。

研究设计与样本

  • 研究纳入360例Xpert Ultra MTBC阳性患者和250例Xpert Ultra MTBC阴性患者的痰标本,以GenoType MTBDRplus为参考,Sanger测序解决不一致。

主要发现

  • FluoroType MTB VER 2.0检测MTBC敏感性手动提取为91.6%(294/321),自动提取为92.1%(305/331)。
  • FluoroType MTBDR VER 2.0检测MTBC敏感性手动提取为89.8%(291/324),自动提取为87.7%(291/332)。
  • FluoroType MTB VER 2.0与MTBDR VER 2.0检测MTBC敏感性比较:手动提取p=0.4,自动提取p=0.05。
  • FluoroType MTBDR VER 2.0对MTBC及利福平、异烟肼耐药的诊断准确性与先前报道的VER 1.0相当。

临床怎么用

  • FluoroType MTB和MTBDR VER 2.0联合自动DNA提取与PCR平台可能提高实验室检测MTBC及利福平、异烟肼耐药的效率。
  • 该检测组合有望用于集中式分子药敏检测模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the accuracy of two new molecular diagnostic tests for the detection of drug-resistant tuberculosis, the FluoroType MTB and MTBDR VER 2.0 assays, in combination with manual and automated DNA extraction methods. METHODS: Sputa from 360 Xpert Ultra Mycobacterium tuberculosis complex (MTBC)-positive patients and 250 Xpert Ultra MTBC-negative patients were tested. GenoType MTBDRplus served as reference for MTBC and drug resistance detection. Sanger sequencing was used to resolve discrepancies. RESULTS: FluoroType MTB VER 2.0 showed similar MTBC sensitivity compared with FluoroType MTBDR VER 2.0 (manual DNA extraction: 91.6% (294/321) versus 89.8% (291/324); p 0.4); automated DNA extraction: 92.1% (305/331) versus 87.7% (291/332); p 0.05)). FluoroType MTBDR VER2.0 showed comparable diagnostic accuracy to FluoroType MTBDR VER1.0 as previously reported for the detection of MTBC and rifampicin and isoniazid resistance. CONCLUSIONS: The FluoroType MTB and MTBDR VER 2.0 assays together with an automated DNA extraction and PCR set-up platform may improve laboratory operational efficiency for the diagnosis of MTBC and resistance to rifampicin and isoniazid and show promise for the implementation in a centralized molecular drug susceptibility testing model.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Dippenaar A, Derendinger B, Dolby T, et al. Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance. Clin Microbiol Infect. 2021. PMID: 33933566. doi:10.1016/j.cmi.2021.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。